← Back to Search

Other

Anodyne Therapy for Lower Extremity Ischemic Pain (DTSC Trial)

N/A
Waitlist Available
Led By Doyce Cartrett, M.D.
Research Sponsored by American Association of Sensory Electrodiagnostic Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

DTSC Trial Summary

This trial will test whether a combination of two therapies, Monochromatic Infrared Photo Energy (MIRE) and Transcutaneous Electrical Nerve Stimulation (TENS), is effective in treating lower extremity pathologies derived from neurological ischemia disorders.

Who is the study for?
This trial is for individuals with lower extremity pain and swelling due to ischemia, who are likely to live at least 5 more years and can follow the study schedule. They must understand and sign a consent form. People may be excluded based on other factors that could affect their participation as judged by the investigator.Check my eligibility
What is being tested?
The trial is testing how well Monochromatic Infrared Photo Energy (MIRE) combined with Transcutaneous Electrical Nerve Stimulation (TENS) therapies work in treating leg pain and swelling caused by neurological ischemia.See study design
What are the potential side effects?
Possible side effects of MIRE and TENS treatments include skin irritation at the site of application, mild discomfort during treatment, muscle twitching, or unusual sensations like tingling.

DTSC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
: Scientific record of treatment success or failure

DTSC Trial Design

1Treatment groups
Experimental Treatment
Group I: AnodyneExperimental Treatment1 Intervention
To evaluate the efficacy treatment of lower extremity pathologies from neurological ischemia disorders using the Monochromatic Infrared Photo Energy (MIRE)

Find a Location

Who is running the clinical trial?

American Association of Sensory Electrodiagnostic MedicineLead Sponsor
1 Previous Clinical Trials
1,000 Total Patients Enrolled
Doyce Cartrett, M.D.Principal InvestigatorAmerican Association of Sensory Electrodiagnostic Medicine
Donald S Covington, M.D.Principal InvestigatorAmerican Association of Sensory Electrodiagnostic Medicine

Media Library

Acute Lower Extremity Swelling Research Study Groups: Anodyne

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants currently being sought for this experiment?

"Per clinicaltrials.gov, the trial originally posted on March 1st 2012 has ceased recruitment efforts and was last updated October 22nd 2022; however there are still 405 alternative trials that continue to accept participants."

Answered by AI

Are those who are younger than 35 eligible for this experiment?

"The parameters for qualification in this trial stipulate that participants must be aged between 25 and 90 years old. Simultaneously, there are 32 clinical trials available to those under 18 and 377 to individuals over 65."

Answered by AI

What number of medical centers are actively engaged in this research endeavor?

"Four research facilities are currently running this trial, including Erie Medical and Rehab in Erie, Silsbee Family Medicine PA in Silsbee, Curequest Clinical LLC in Jacksonville; other sites are also participating."

Answered by AI

What criteria must a person satisfy to be accepted into this research?

"This trial necessitates an enrollment of 1000 individuals aged 25 to 90 suffering from lower extremity issues. Furthermore, the participants must have a high likelihood of surviving five years in addition to adhering to all study visit schedules as judged by the investigator."

Answered by AI
~127 spots leftby Jan 2026